Complex Differential Diagnosis between Primary Breast Cancer and Breast Metastasis from EGFR-Mutated Lung Adenocarcinoma: Case Report and Literature Review.


Journal

Current oncology (Toronto, Ont.)
ISSN: 1718-7729
Titre abrégé: Curr Oncol
Pays: Switzerland
ID NLM: 9502503

Informations de publication

Date de publication:
31 08 2021
Historique:
received: 26 07 2021
revised: 24 08 2021
accepted: 26 08 2021
entrez: 30 9 2021
pubmed: 1 10 2021
medline: 28 10 2021
Statut: epublish

Résumé

We present a case of a woman with epidermal growth factor receptor (EGFR)-mutated lung adenocarcinoma who received gefitinib for 2 years and obtained a partial response. The patient then developed liver metastasis and a breast lesion, displaying high estrogen receptor (ER) expression and harboring the same EGFR mutation. From the radiological studies, it was not possible to make a differential diagnosis between primary breast cancer and breast metastasis from lung cancer. After the removal of the breast nodule, thanks to the clinical history, radiology, and above all, molecular and immunohistochemical investigations, a diagnosis of breast metastasis from lung adenocarcinoma was made. This case emphasizes the importance of a comprehensive clinical, pathological, and molecular analysis in the differential diagnosis between primary breast cancer and metastases from extramammary tumor to guide adequate treatment decision making.

Identifiants

pubmed: 34590588
pii: curroncol28050292
doi: 10.3390/curroncol28050292
pmc: PMC8482094
doi:

Substances chimiques

EGFR protein, human EC 2.7.10.1
ErbB Receptors EC 2.7.10.1

Types de publication

Case Reports Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

3384-3392

Références

Histopathology. 2020 Aug;77(2):303-313
pubmed: 32396659
J Pathol Transl Med. 2020 Jan;54(1):103-111
pubmed: 31718122
Steroids. 2007 Feb;72(2):135-43
pubmed: 17276470
Cancer Biol Med. 2014 Sep;11(3):208-15
pubmed: 25364582
Diagn Pathol. 2010 Jun 17;5:37
pubmed: 20565809
J Clin Ultrasound. 2011 Jun;39(5):248-55
pubmed: 21469153
Cancer. 2007 Aug 15;110(4):731-7
pubmed: 17582626
J Thorac Cardiovasc Surg. 2005 Oct;130(4):979-86
pubmed: 16214508
BMC Cancer. 2014 Oct 01;14:736
pubmed: 25274100
Biomed Pharmacother. 2012 Jul;66(5):384-9
pubmed: 22560634
Ultrasound Q. 2013 Sep;29(3):205-9
pubmed: 23975047
Lung Cancer. 2011 Nov;74(2):352-3
pubmed: 21944773
Pathol Res Pract. 2005;201(8-9):579-86
pubmed: 16259111
Arch Surg. 1999 Apr;134(4):450
pubmed: 10199322
Am J Clin Pathol. 2005 Jan;123(1):21-7
pubmed: 15762276
BMC Cancer. 2016 Aug 03;16:593
pubmed: 27488410
Gynecol Obstet Fertil. 2007 Jun;35(6):536-40
pubmed: 17543568
Clin Cancer Res. 2020 Jul 1;26(13):3172-3181
pubmed: 32144133
Histopathology. 2000 Jan;36(1):8-16
pubmed: 10632746
Korean J Radiol. 2014 Jan-Feb;15(1):20-8
pubmed: 24497788
Int J Surg Pathol. 2016 Aug;24(5):377-81
pubmed: 26842346
Cytojournal. 2010 Jul 02;7:10
pubmed: 20806071
J Clin Pathol. 2007 Dec;60(12):1333-41
pubmed: 18042689
Clin Case Rep. 2018 Jun 19;6(8):1510-1516
pubmed: 30147894
J Surg Res. 2014 May 15;188(2):419-31
pubmed: 24560348
Breast Dis. 2015;35(3):207-10
pubmed: 26406545
Am J Surg Pathol. 2010 Dec;34(12):1881-5
pubmed: 21107096
Respirol Case Rep. 2013 Sep;1(1):20-2
pubmed: 25473531
Acad Radiol. 2011 May;18(5):565-74
pubmed: 21393030
J Thorac Oncol. 2013 Jul;8(7):974-9
pubmed: 23774384
Virchows Arch. 2018 May;472(5):771-777
pubmed: 29105026
Nat Rev Cancer. 2019 Sep;19(9):495-509
pubmed: 31406302
J Thorac Oncol. 2013 Jul;8(7):923-9
pubmed: 23608817
J Thorac Dis. 2018 Jan;10(1):482-497
pubmed: 29600083
Histopathology. 2016 Jan;68(1):86-95
pubmed: 26768031
Am J Surg Pathol. 2008 Mar;32(3):426-32
pubmed: 18300807
Am J Surg Pathol. 2014 Jan;38(1):13-22
pubmed: 24145643
Case Rep Oncol. 2015 Mar 14;8(1):164-8
pubmed: 25873885
Case Rep Oncol. 2012 Sep;5(3):546-53
pubmed: 23139670
Cancer. 2001 Nov 1;92(9):2259-66
pubmed: 11745279
Appl Immunohistochem Mol Morphol. 2015 Oct;23(9):653-60
pubmed: 25789532
Mod Pathol. 2013 Mar;26(3):343-9
pubmed: 23174933
Lung Cancer. 2018 Sep;123:91-98
pubmed: 30089602
BMJ Case Rep. 2016 Sep 01;2016:
pubmed: 27587745
J Clin Oncol. 2009 Jan 20;27(3):411-7
pubmed: 19064969
Semin Ultrasound CT MR. 2000 Oct;21(5):375-94
pubmed: 11071618
Appl Immunohistochem Mol Morphol. 2010 Mar;18(2):137-41
pubmed: 19875957
Breast Cancer Res. 2011 Apr 01;13(2):R35
pubmed: 21457545
Nat Rev Cancer. 2007 Oct;7(10):778-90
pubmed: 17882278
APMIS. 2009 Oct;117(10):762-7
pubmed: 19775345

Auteurs

Carmine Valenza (C)

Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141 Milan, Italy.
Department of Oncology and Hemato-Oncology (DIPO), University of Milan, Via Festa del Perdono 7, 20122 Milan, Italy.

Francesca Maria Porta (FM)

Division of Pathology and Laboratory Medicine, European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141 Milan, Italy.
School of Pathology, University of Milan, Via Festa del Perdono 7, 20122 Milan, Italy.

Alessandra Rappa (A)

Division of Pathology and Laboratory Medicine, European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141 Milan, Italy.

Elena Guerini-Rocco (E)

Department of Oncology and Hemato-Oncology (DIPO), University of Milan, Via Festa del Perdono 7, 20122 Milan, Italy.
Division of Pathology and Laboratory Medicine, European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141 Milan, Italy.

Giuseppe Viale (G)

Department of Oncology and Hemato-Oncology (DIPO), University of Milan, Via Festa del Perdono 7, 20122 Milan, Italy.
Division of Pathology and Laboratory Medicine, European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141 Milan, Italy.

Massimo Barberis (M)

Division of Pathology and Laboratory Medicine, European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141 Milan, Italy.

Filippo de Marinis (F)

Division of Thoracic Oncology, European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141 Milan, Italy.

Giuseppe Curigliano (G)

Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141 Milan, Italy.
Department of Oncology and Hemato-Oncology (DIPO), University of Milan, Via Festa del Perdono 7, 20122 Milan, Italy.

Chiara Catania (C)

Division of Thoracic Oncology, European Institute of Oncology, IRCCS, Via Ripamonti 435, 20141 Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH